MOUNTAIN VIEW, Calif., April 10, 2024 -- IGM Biosciences, Inc. , a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief...
Related Keywords
Fred Schwarzer , David Pitts , Nasdaq , Virtual Targeted Oncology Forum On , Biosciences Inc , Chief Executive Officer , Targeted Oncology Forum , Markets ,
vimarsana.com © 2020. All Rights Reserved.